Ox2 Therapeutics, Inc.

Manufacturing · Minneapolis, MN

✓ AI-Ready Profile
71
AI Score

🤖 AI-Optimized Summary

THE FDA GRANTS IND APPROVAL TO OX2 THERAPEUTICS TO PROCEED WITH CLINICAL DEVELOPMENT OF ITS PEPTIDE LIGAND CHECKPOINT INHIBITOR FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS

📋 Business Details

Minneapolis, MN
Manufacturing

Is this your business?

Claim this profile to improve your AI Visibility Score and get verified.

Claim My AI Profile →